TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biovac Sverige AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
3,184
|
3,971
|
3,818 |
| Financial expenses |
5
|
12
|
6 |
| Earnings before taxes |
45
|
137
|
-134 |
| EBITDA |
59
|
160
|
-117 |
| Total assets |
1,115
|
1,074
|
1,047 |
| Current assets |
957
|
886
|
845 |
| Current liabilities |
684
|
664
|
773 |
| Equity capital |
431
|
410
|
274 |
| - share capital |
7
|
7
|
7 |
| Employees (average) |
8
|
9
|
9 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
38.7%
|
38.2%
|
26.2% |
| Turnover per employee |
398
|
441
|
424 |
| Profit as a percentage of turnover |
1.4%
|
3.5%
|
-3.5% |
| Return on assets (ROA) |
4.5%
|
13.9%
|
-12.2% |
| Current ratio |
139.9%
|
133.4%
|
109.3% |
| Return on equity (ROE) |
10.4%
|
33.4%
|
-48.9% |
| Change turnover |
-651
|
142
|
-18 |
| Change turnover % |
-17%
|
4%
|
0% |
| Chg. No. of employees |
-1
|
0
|
1 |
| Chg. No. of employees % |
-11%
|
0%
|
13% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.